# Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel

> **NCT05486247** · — · COMPLETED · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 32 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05486247
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-04
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486247, "Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05486247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*